Various clinical studies attempting to correlate resistin with the progression and severity of chronic T2D complications have reported a tendency toward an increased risk of these conditions in individuals with elevated resistin levels compared to healthy subjects. The gene discussed is RETN; the disease is type 2 diabetes mellitus.